We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Benign Hematology

Journal Scan / Research · November 18, 2020

Efficacy and Safety of Romiplostim in Refractory Aplastic Anemia

British Journal of Haematology

 

Save Recommend
Share

Additional Info

British Journal of Haematology
Efficacy and Safety of Romiplostim in Refractory Aplastic Anaemia: A Phase II/III, Multicentre, Open-Label Study
Br. J. Haematol 2020 Nov 05;[EPub Ahead of Print], JH Jang, Y Tomiyama, K Miyazaki, K Nagafuji, K Usuki, N Uoshima, T Fujisaki, H Kosugi, I Matsumura, K Sasaki, M Kizaki, M Sawa, M Hidaka, N Kobayashi, S Ichikawa, Y Yonemura, K Enokitani, A Matsuda, K Ozawa, K Mitani, JW Lee, S Nakao

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated